{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:53:14Z","timestamp":1769881994189,"version":"3.49.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000266","name":"engineering and physical sciences research council","doi-asserted-by":"publisher","award":["EP\/R015139\/1"],"award-info":[{"award-number":["EP\/R015139\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"rosetrees trust","doi-asserted-by":"publisher","award":["A2750\/M874"],"award-info":[{"award-number":["A2750\/M874"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bio-des. Manuf."],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone cancer is a critical health problem on a global scale, and the associated huge clinical and economic burdens are still rising. Although many clinical approaches are currently used for bone cancer treatment, these methods usually affect the normal body functions and thus present significant limitations. Meanwhile, advanced materials and additive manufacturing have opened up promising avenues for the development of new strategies targeting both bone cancer treatment and post-treatment bone regeneration. This paper presents a comprehensive review of bone cancer and its current treatment methods, particularly focusing on a number of advanced strategies such as scaffolds based on advanced functional materials, drug-loaded scaffolds, and scaffolds for photothermal\/magnetothermal therapy. Finally, the main research challenges and future perspectives are elaborated.<\/jats:p>","DOI":"10.1007\/s42242-022-00182-7","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T09:02:57Z","timestamp":1646643777000},"page":"556-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Application of additively manufactured 3D scaffolds for bone cancer treatment: a review"],"prefix":"10.1007","volume":"5","author":[{"given":"Yanhao","family":"Hou","sequence":"first","affiliation":[]},{"given":"Weiguang","family":"Wang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-726X","authenticated-orcid":false,"given":"Paulo","family":"Bartolo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"182_CR1","unstructured":"All cancers fact. (2020) World Health Organization"},{"issue":"7","key":"182_CR2","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","volume":"29","author":"AB Mariotto","year":"2020","unstructured":"Mariotto AB, Enewold L, Zhao J et al (2020) Medical care costs associated with cancer survivorship in the united states. Cancer Epidemiol Biomarkers Prev 29(7):1304\u20131312. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-1534","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"182_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejca.2020.01.011","volume":"129","author":"T Hofmarcher","year":"2020","unstructured":"Hofmarcher T, Lindgren P, Wilking N et al (2020) The cost of cancer in Europe 2018. Eur J Cancer 129:41\u201349. https:\/\/doi.org\/10.1016\/j.ejca.2020.01.011","journal-title":"Eur J Cancer"},{"key":"182_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.abb.2014.07.013","volume":"561","author":"M Van Driel","year":"2014","unstructured":"Van Driel M, Van Leeuwen JP (2014) Cancer and bone: a complex complex. Arch Biochem Biophys 561:159\u2013166. https:\/\/doi.org\/10.1016\/j.abb.2014.07.013","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"182_CR5","first-page":"92","volume":"9","author":"A Franchi","year":"2012","unstructured":"Franchi A (2012) Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab 9(2):92\u201395","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"5","key":"182_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/Bco.0000000000000405","volume":"27","author":"N Kumar","year":"2016","unstructured":"Kumar N, Gupta B (2016) Global incidence of primary malignant bone tumors. Curr Orthop Pract 27(5):530\u2013534. https:\/\/doi.org\/10.1097\/Bco.0000000000000405","journal-title":"Curr Orthop Pract"},{"issue":"2","key":"182_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00223-017-0372-2","volume":"102","author":"HK Brown","year":"2018","unstructured":"Brown HK, Schiavone K, Gouin F et al (2018) Biology of bone sarcomas and new therapeutic developments. Calcif Tissue Int 102(2):174\u2013195. https:\/\/doi.org\/10.1007\/s00223-017-0372-2","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 7","key":"182_CR8","doi-asserted-by":"publisher","first-page":"vii100","DOI":"10.1093\/annonc\/mds254","volume":"23","author":"Group EESNW","year":"2012","unstructured":"Group EESNW (2012) Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii100\u2013vii109. https:\/\/doi.org\/10.1093\/annonc\/mds254","journal-title":"Ann Oncol"},{"issue":"Suppl","key":"182_CR9","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3816\/cbc.2007.s.001","volume":"7","author":"HA Harvey","year":"2007","unstructured":"Harvey HA, Cream L (2007) Biology of bone metastases: causes and consequences. Clin Breast Cancer 7(Suppl):S7\u2013S13. https:\/\/doi.org\/10.3816\/cbc.2007.s.001","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"182_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/ID.0b013e3180312011","volume":"16","author":"JD Bumgardner","year":"2007","unstructured":"Bumgardner JD, Chesnutt BM, Yuan Y et al (2007) The integration of chitosan-coated titanium in bone: an in vivo study in rabbits. Implant Dent 16(1):66\u201379. https:\/\/doi.org\/10.1097\/ID.0b013e3180312011","journal-title":"Implant Dent"},{"issue":"1","key":"182_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jbm.b.30357","volume":"76b","author":"H Hattori","year":"2006","unstructured":"Hattori H, Masuoka K, Sato M et al (2006) Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold. J Biomed Mater Res B 76b(1):230\u2013239. https:\/\/doi.org\/10.1002\/jbm.b.30357","journal-title":"J Biomed Mater Res B"},{"key":"182_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13569-016-0047-1","volume":"6","author":"C Gerrand","year":"2016","unstructured":"Gerrand C, Athanasou N, Brennan B et al (2016) UK guidelines for the management of bone sarcomas. Clin Sarcoma Res 6:7. https:\/\/doi.org\/10.1186\/s13569-016-0047-1","journal-title":"Clin Sarcoma Res"},{"key":"182_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4020-9819-2_14","volume":"12","author":"T Makatsoris","year":"2009","unstructured":"Makatsoris T, Kalofonos HP (2009) The role of chemotherapy in the treatment of bone metastases. Cancer Metastasis Biol Treat 12:287\u2013298. https:\/\/doi.org\/10.1007\/978-1-4020-9819-2_14","journal-title":"Cancer Metastasis Biol Treat"},{"key":"182_CR14","first-page":"47","volume":"1","author":"MH Hanigan","year":"2003","unstructured":"Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47\u201361","journal-title":"Cancer Ther"},{"issue":"4","key":"182_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2011","unstructured":"Volkova M, Russell R 3rd (2011) Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev 7(4):214\u2013220. https:\/\/doi.org\/10.2174\/157340311799960645","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"182_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","volume":"49","author":"G Takemura","year":"2007","unstructured":"Takemura G, Fujiwara H (2007) Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49(5):330\u2013352. https:\/\/doi.org\/10.1016\/j.pcad.2006.10.002","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"182_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/152308601750100641","volume":"3","author":"D Kumar","year":"2001","unstructured":"Kumar D, Kirshenbaum LA, Li T et al (2001) Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal 3(1):135\u2013145. https:\/\/doi.org\/10.1089\/152308601750100641","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"182_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/toxics3020152","volume":"3","author":"R Velasco","year":"2015","unstructured":"Velasco R, Bruna J (2015) Taxane-induced peripheral neurotoxicity. Toxics 3(2):152\u2013169. https:\/\/doi.org\/10.3390\/toxics3020152","journal-title":"Toxics"},{"key":"182_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fphar.2013.00057","volume":"4","author":"MO Palumbo","year":"2013","unstructured":"Palumbo MO, Kavan P, Miller WH et al (2013) Systemic cancer therapy: achievements and challenges that lie ahead. Front Pharmacol 4:57. https:\/\/doi.org\/10.3389\/fphar.2013.00057","journal-title":"Front Pharmacol"},{"issue":"1","key":"182_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/btm2.10003","volume":"1","author":"AC Anselmo","year":"2016","unstructured":"Anselmo AC, Mitragotri S (2016) Nanoparticles in the clinic. Bioeng Transl Med 1(1):10\u201329. https:\/\/doi.org\/10.1002\/btm2.10003","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"182_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12951-016-0233-6","volume":"14","author":"S Rudnick-Glick","year":"2016","unstructured":"Rudnick-Glick S, Corem-Salkmon E, Grinberg I et al (2016) Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model. J Nanobiotechnol 14(1):80. https:\/\/doi.org\/10.1186\/s12951-016-0233-6","journal-title":"J Nanobiotechnol"},{"issue":"9","key":"182_CR22","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/ma11091485","volume":"11","author":"P Ahangar","year":"2018","unstructured":"Ahangar P, Akoury E, Ramirez Garcia Luna AS et al (2018) Nanoporous 3D-printed scaffolds for local doxorubicin delivery in bone metastases secondary to prostate cancer. Materials (Basel) 11(9):1485. https:\/\/doi.org\/10.3390\/ma11091485","journal-title":"Materials (Basel)"},{"issue":"5","key":"182_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1177\/00220345710500053001","volume":"50","author":"DE Gardner","year":"1971","unstructured":"Gardner DE, Mitchell DF, Mcdonald RE (1971) Treatment of pulps of monkeys with vancomycin and calcium hydroxide. J Dent Res 50(5):1273\u20131277. https:\/\/doi.org\/10.1177\/00220345710500053001","journal-title":"J Dent Res"},{"key":"182_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2474-7-18","volume":"7","author":"HP Stallmann","year":"2006","unstructured":"Stallmann HP, Faber C, Bronckers AL et al (2006) In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile. BMC Musculoskelet Disord 7:18. https:\/\/doi.org\/10.1186\/1471-2474-7-18","journal-title":"BMC Musculoskelet Disord"},{"issue":"6815","key":"182_CR25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/35050141","volume":"408","author":"KY Lee","year":"2000","unstructured":"Lee KY, Peters MC, Anderson KW et al (2000) Controlled growth factor release from synthetic extracellular matrices. Nature 408(6815):998\u20131000. https:\/\/doi.org\/10.1038\/35050141","journal-title":"Nature"},{"issue":"2","key":"182_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/35050141","volume":"134","author":"X Niu","year":"2009","unstructured":"Niu X, Feng Q, Wang M et al (2009) Porous nano-HA\/collagen\/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Contr Release 134(2):111\u2013117. https:\/\/doi.org\/10.1038\/35050141","journal-title":"J Contr Release"},{"key":"182_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.addr.2018.05.006","volume":"132","author":"SH Lim","year":"2018","unstructured":"Lim SH, Kathuria H, Tan JJY et al (2018) 3D printed drug delivery and testing systems\u2014a passing fad or the future? Adv Drug Del Rev 132:139\u2013168. https:\/\/doi.org\/10.1016\/j.addr.2018.05.006","journal-title":"Adv Drug Del Rev"},{"issue":"5","key":"182_CR28","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1302\/0301-620X.71B5.2584251","volume":"71","author":"P Hernigou","year":"1989","unstructured":"Hernigou P, Thiery JP, Benoit J et al (1989) Methotrexate diffusion from acrylic cement. Local chemotherapy for bone tumours. J Bone Joint Surg Br 71(5):804\u2013811. https:\/\/doi.org\/10.1302\/0301-620X.71B5.2584251","journal-title":"J Bone Joint Surg Br"},{"key":"182_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.actbio.2015.02.004","volume":"18","author":"M Sun","year":"2015","unstructured":"Sun M, Wang M, Chen M et al (2015) A tissue-engineered therapeutic device inhibits tumor growth in vitro and in vivo. Acta Biomater 18:21\u201329. https:\/\/doi.org\/10.1016\/j.actbio.2015.02.004","journal-title":"Acta Biomater"},{"issue":"7","key":"182_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tibtech.2004.05.005","volume":"22","author":"DW Hutmacher","year":"2004","unstructured":"Hutmacher DW, Sittinger M, Risbud MV (2004) Scaffold-based tissue engineering: Rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol 22(7):354\u2013362. https:\/\/doi.org\/10.1016\/j.tibtech.2004.05.005","journal-title":"Trends Biotechnol"},{"key":"182_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.109891","volume":"104","author":"W Wei","year":"2019","unstructured":"Wei W, Zhang X, Zhang S et al (2019) Biomedical and bioactive engineered nanomaterials for targeted tumor photothermal therapy: a review. Mater Sci Eng C Mater Biol Appl 104:109891. https:\/\/doi.org\/10.1016\/j.msec.2019.109891","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"182_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.actbio.2018.08.026","volume":"79","author":"H Ma","year":"2018","unstructured":"Ma H, Feng C, Chang J et al (2018) 3D-printed bioceramic scaffolds: From bone tissue engineering to tumor therapy. Acta Biomater 79:37\u201359. https:\/\/doi.org\/10.1016\/j.actbio.2018.08.026","journal-title":"Acta Biomater"},{"issue":"3","key":"182_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/1097-4636(2001)58:3<329::aid-jbm1025>3.0.co;2-9","volume":"58","author":"MR Sarkar","year":"2001","unstructured":"Sarkar MR, Wachter N, Patka P et al (2001) First histological observations on the incorporation of a novel calcium phosphate bone substitute material in human cancellous bone. J Biomed Mater Res 58(3):329\u2013334. https:\/\/doi.org\/10.1002\/1097-4636(2001)58:3%3c329::aid-jbm1025%3e3.0.co;2-9","journal-title":"J Biomed Mater Res"},{"key":"182_CR34","doi-asserted-by":"publisher","unstructured":"Madanagopal TT, Agarwalla SV, Rosa V (2019) 3\u2014Carbon nanocomposites for implant dentistry and bone tissue engineering. In: Applications of nanocomposite materials in dentistry. Woodhead Publishing, pp 47\u201363. https:\/\/doi.org\/10.1016\/B978-0-12-813742-0.00003-1","DOI":"10.1016\/B978-0-12-813742-0.00003-1"},{"key":"182_CR35","doi-asserted-by":"publisher","DOI":"10.1201\/9781420033342","volume-title":"The physical measurement of bone","author":"CM Langton","year":"2016","unstructured":"Langton CM, Njeh CF (2016) The physical measurement of bone. CRC Press, Boca Raton"},{"key":"182_CR36","doi-asserted-by":"publisher","unstructured":"Arnett T (2016) Bone structure and function: organization & composition of bone, bone modelling and remodelling, bone cells. In: 43rd Annual european calcified tissue society congress. BioScientifica. https:\/\/doi.org\/10.1530\/boneabs.5.AHP1.1","DOI":"10.1530\/boneabs.5.AHP1.1"},{"key":"182_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.actbio.2019.08.020","volume":"99","author":"EC Gonzalez Diaz","year":"2019","unstructured":"Gonzalez Diaz EC, Sinha S, Avedian RS et al (2019) Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression. Acta Biomater 99:18\u201332. https:\/\/doi.org\/10.1016\/j.actbio.2019.08.020","journal-title":"Acta Biomater"},{"key":"182_CR38","first-page":"321","volume-title":"WHO classification of tumors of soft tissue and bone","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, Hogendoorn P, Mertens F (2013) WHO classification of tumors of soft tissue and bone. IARC Press, Lyon, pp 321\u2013324"},{"key":"182_CR39","unstructured":"Perrin W (2014) Osteosarcoma information for patients. Oxford University Hospitals NHS Trust."},{"issue":"6","key":"182_CR40","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/annonc\/mdr491","volume":"23","author":"JS Whelan","year":"2012","unstructured":"Whelan JS, Jinks RC, Mctiernan A et al (2012) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European osteosarcoma intergroup randomised controlled trials. Ann Oncol 23(6):1607\u20131616. https:\/\/doi.org\/10.1093\/annonc\/mdr491","journal-title":"Ann Oncol"},{"key":"182_CR41","unstructured":"Dennis N, Francis M, Lawrence G (2012) Bone sarcoma incidence and survival. Tumours diagnosed between 1985 and 2009. National Cancer Intelligence Network"},{"issue":"1","key":"182_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mpsur.2014.10.006","volume":"33","author":"AK Freeman","year":"2015","unstructured":"Freeman AK, Sumathi VP, Jeys L (2015) Primary malignant tumours of the bone. Surg Infect (Larchmt) 33(1):26\u201333. https:\/\/doi.org\/10.1016\/j.mpsur.2014.10.006","journal-title":"Surg Infect (Larchmt)"},{"issue":"7","key":"182_CR43","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","volume":"115","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115(7):1531\u20131543. https:\/\/doi.org\/10.1002\/cncr.24121","journal-title":"Cancer"},{"issue":"1","key":"182_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mpsur.2017.10.001","volume":"36","author":"AK Freeman","year":"2018","unstructured":"Freeman AK, Sumathi VP, Jeys L (2018) Primary malignant tumours of the bone. Surg Infect (Larchmt) 36(1):27\u201334. https:\/\/doi.org\/10.1016\/j.mpsur.2017.10.001","journal-title":"Surg Infect (Larchmt)"},{"issue":"Suppl 4","key":"182_CR45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdp155","volume":"20","author":"M Paulussen","year":"2009","unstructured":"Paulussen M, Bielack S, J\u00fcrgens H et al (2009) Ewing\u2019s sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):140\u2013142. https:\/\/doi.org\/10.1093\/annonc\/mdp155","journal-title":"Ann Oncol"},{"key":"182_CR46","doi-asserted-by":"publisher","first-page":"317462","DOI":"10.1155\/2010\/317462","volume":"2010","author":"R Grimer","year":"2010","unstructured":"Grimer R, Athanasou N, Gerrand C et al (2010) UK guidelines for the management of bone sarcomas. Sarcoma 2010:317462. https:\/\/doi.org\/10.1155\/2010\/317462","journal-title":"Sarcoma"},{"issue":"17","key":"182_CR47","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1200\/jco.2000.18.17.3108","volume":"18","author":"SJ Cotterill","year":"2000","unstructured":"Cotterill SJ, Ahrens S, Paulussen M et al (2000) Prognostic factors in Ewing\u2019s tumor of bone: analysis of 975 patients from the European intergroup cooperative Ewing\u2019s sarcoma study group. J Clin Oncol 18(17):3108\u20133114. https:\/\/doi.org\/10.1200\/jco.2000.18.17.3108","journal-title":"J Clin Oncol"},{"issue":"5","key":"182_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1634\/theoncologist.11-5-503","volume":"11","author":"M Bernstein","year":"2006","unstructured":"Bernstein M, Kovar H, Paulussen M et al (2006) Ewing\u2019s sarcoma family of tumors: current management. Oncologist 11(5):503\u2013519. https:\/\/doi.org\/10.1634\/theoncologist.11-5-503","journal-title":"Oncologist"},{"issue":"5","key":"182_CR49","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1056\/NEJM199408043310503","volume":"331","author":"O Delattre","year":"1994","unstructured":"Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331(5):294\u2013299. https:\/\/doi.org\/10.1056\/NEJM199408043310503","journal-title":"N Engl J Med"},{"issue":"12","key":"182_CR50","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1634\/theoncologist.2011-0200","volume":"16","author":"SH Verdegaal","year":"2011","unstructured":"Verdegaal SH, Bovee JV, Pansuriya TC et al (2011) Incidence, predictive factors, and prognosis of chondrosarcoma in patients with ollier disease and maffucci syndrome: an international multicenter study of 161 patients. Oncologist 16(12):1771\u20131779. https:\/\/doi.org\/10.1634\/theoncologist.2011-0200","journal-title":"Oncologist"},{"issue":"1","key":"182_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4081\/oncol.2017.321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F et al (2017) Bone metastases: an overview. Oncol Rev 11(1):321. https:\/\/doi.org\/10.4081\/oncol.2017.321","journal-title":"Oncol Rev"},{"issue":"4","key":"182_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.euus.2005.09.006","volume":"3","author":"MG Cecchini","year":"2005","unstructured":"Cecchini MG, Wetterwald A, van der Pluijm G et al (2005) Molecular and biological mechanisms of bone metastasis. EAU Updat Ser 3(4):214\u2013226. https:\/\/doi.org\/10.1016\/j.euus.2005.09.006","journal-title":"EAU Updat Ser"},{"issue":"2","key":"182_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1055-3207(18)30063-2","volume":"10","author":"AF Chambers","year":"2001","unstructured":"Chambers AF, Naumov GN, Varghese HJ et al (2001) Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 10(2):243\u2013255","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"182_CR54","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","volume":"153","author":"KJ Luzzi","year":"1998","unstructured":"Luzzi KJ, Macdonald IC, Schmidt EE et al (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153(3):865\u2013873. https:\/\/doi.org\/10.1016\/S0002-9440(10)65628-3","journal-title":"Am J Pathol"},{"issue":"3","key":"182_CR55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.critrevonc.2005.03.011","volume":"56","author":"G Selvaggi","year":"2005","unstructured":"Selvaggi G, Scagliotti GV (2005) Management of bone metastases in cancer: a review. Crit Rev Oncol Hematol 56(3):365\u2013378. https:\/\/doi.org\/10.1016\/j.critrevonc.2005.03.011","journal-title":"Crit Rev Oncol Hematol"},{"key":"182_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4614-5662-9_2","volume-title":"Metastatic bone disease: an integrated approach to patient care","author":"A Chiechi","year":"2016","unstructured":"Chiechi A, Guise TA (2016) Pathobiology of osteolytic and osteoblastic bone metastases. In: Randall RL (ed) Metastatic bone disease: an integrated approach to patient care. Springer, New York, pp 15\u201335. https:\/\/doi.org\/10.1007\/978-1-4614-5662-9_2"},{"issue":"3","key":"182_CR57","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.path.2017.04.006","volume":"10","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Rosenberg AE (2017) Bone-forming tumors. Surg Pathol Clin 10(3):513\u2013535. https:\/\/doi.org\/10.1016\/j.path.2017.04.006","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"182_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jbo.2015.02.001","volume":"4","author":"DN Hakim","year":"2015","unstructured":"Hakim DN, Pelly T, Kulendran M et al (2015) Benign tumours of the bone: a review. J Bone Oncol 4(2):37\u201341. https:\/\/doi.org\/10.1016\/j.jbo.2015.02.001","journal-title":"J Bone Oncol"},{"issue":"1","key":"182_CR59","first-page":"2","volume":"4","author":"A Sobti","year":"2016","unstructured":"Sobti A, Agrawal P, Agarwala S et al (2016) Giant cell tumor of bone-an overview. Arch Bone Jt Surg 4(1):2\u20139","journal-title":"Arch Bone Jt Surg"},{"issue":"1\u20132","key":"182_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2009.07.004","volume":"310","author":"S Casimiro","year":"2009","unstructured":"Casimiro S, Guise TA, Chirgwin J (2009) The critical role of the bone microenvironment in cancer metastases. Mol Cell Endocrinol 310(1\u20132):71\u201381. https:\/\/doi.org\/10.1016\/j.mce.2009.07.004","journal-title":"Mol Cell Endocrinol"},{"issue":"27","key":"182_CR61","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","volume":"261","author":"PV Hauschka","year":"1986","unstructured":"Hauschka PV, Mavrakos AE, Iafrati MD et al (1986) Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-sepharose. J Biol Chem 261(27):12665\u201312674","journal-title":"J Biol Chem"},{"issue":"3","key":"182_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1677\/erc.1.00543","volume":"12","author":"GA Clines","year":"2005","unstructured":"Clines GA, Guise TA (2005) Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 12(3):549\u2013583. https:\/\/doi.org\/10.1677\/erc.1.00543","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"182_CR63","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j","volume":"51","author":"SA Charhon","year":"1983","unstructured":"Charhon SA, Chapuy MC, Delvin EE et al (1983) Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia. Cancer 51(5):918\u2013924. https:\/\/doi.org\/10.1002\/1097-0142(19830301)51:5%3c918::aid-cncr2820510526%3e3.0.co;2-j","journal-title":"Cancer"},{"issue":"1","key":"182_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/1040-8428(94)00122-a","volume":"18","author":"M Koutsilieris","year":"1995","unstructured":"Koutsilieris M (1995) Skeletal metastases in advanced prostate cancer: cell biology and therapy. Crit Rev Oncol Hematol 18(1):51\u201364. https:\/\/doi.org\/10.1016\/1040-8428(94)00122-a","journal-title":"Crit Rev Oncol Hematol"},{"key":"182_CR65","unstructured":"Treating Bone Metastasis (2021) WebMD. https:\/\/www.webmd.com\/cancer\/treating-bone-metastasis-breast-cancer. Accessed 1 July 2021"},{"key":"182_CR66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2017.05.023","volume":"110","author":"C Canal","year":"2017","unstructured":"Canal C, Fontelo R, Hamouda I et al (2017) Plasma-induced selectivity in bone cancer cells death. Free Radic Biol Med 110:72\u201380. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.05.023","journal-title":"Free Radic Biol Med"},{"key":"182_CR67","unstructured":"Bone Cancer Treatment (2021) National Health Service. https:\/\/www.nhs.uk\/conditions\/bone-cancer\/treatment\/. Accessed 1 July 2021"},{"key":"182_CR68","doi-asserted-by":"publisher","first-page":"494381","DOI":"10.1155\/2011\/494381","volume":"2011","author":"PS Rose","year":"2011","unstructured":"Rose PS, Clarke MJ, Dekutoski MB (2011) Minimally invasive treatment of spinal metastases: Techniques. Int J Surg Oncol 2011:494381. https:\/\/doi.org\/10.1155\/2011\/494381","journal-title":"Int J Surg Oncol"},{"issue":"6","key":"182_CR69","first-page":"1123","volume":"65","author":"JC Wittig","year":"2002","unstructured":"Wittig JC, Bickels J, Priebat D et al (2002) Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 65(6):1123\u20131132","journal-title":"Am Fam Physician"},{"key":"182_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00003086-198011000-00013","volume":"153","author":"WF Enneking","year":"1980","unstructured":"Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106\u2013120","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"182_CR71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jso.20628","volume":"96","author":"G Bacci","year":"2007","unstructured":"Bacci G, Forni C, Longhi A et al (2007) Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol 96(2):118\u2013123. https:\/\/doi.org\/10.1002\/jso.20628","journal-title":"J Surg Oncol"},{"issue":"5","key":"182_CR72","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/1097-0142(19810301)47:5<1005::aid-cncr2820470532>3.0.co;2-9","volume":"47","author":"WF Enneking","year":"1981","unstructured":"Enneking WF, Spanier SS, Malawer MM (1981) The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer 47(5):1005\u20131022. https:\/\/doi.org\/10.1002\/1097-0142(19810301)47:5%3c1005::aid-cncr2820470532%3e3.0.co;2-9","journal-title":"Cancer"},{"issue":"3","key":"182_CR73","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mporth.2017.03.012","volume":"31","author":"KH Steele","year":"2017","unstructured":"Steele KH, Raurell A, Ashford RU (2017) Surgical management of soft tissue sarcoma. Orthop Trauma 31(3):180\u2013187. https:\/\/doi.org\/10.1016\/j.mporth.2017.03.012","journal-title":"Orthop Trauma"},{"issue":"8","key":"182_CR74","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.spinee.2010.05.017","volume":"10","author":"AJ Schoenfeld","year":"2010","unstructured":"Schoenfeld AJ, Hornicek FJ, Pedlow FX et al (2010) Osteosarcoma of the spine: experience in 26 patients treated at the massachusetts general hospital. Spine J 10(8):708\u2013714. https:\/\/doi.org\/10.1016\/j.spinee.2010.05.017","journal-title":"Spine J"},{"issue":"4","key":"182_CR75","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1302\/0301-620x.79b4.7687","volume":"79b","author":"RJ Grimer","year":"1997","unstructured":"Grimer RJ, Carter SR, Pynsent PB (1997) The cost-effectiveness of limb salvage for bone tumours. J Bone Joint Surg Br 79b(4):558\u2013561. https:\/\/doi.org\/10.1302\/0301-620x.79b4.7687","journal-title":"J Bone Joint Surg Br"},{"issue":"11","key":"182_CR76","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1302\/0301-620X.96B11.34747","volume":"96-B","author":"ER Henderson","year":"2014","unstructured":"Henderson ER, O\u2019connor MI, Ruggieri P et al (2014) Classification of failure of limb salvage after reconstructive surgery for bone tumours: a modified system including biological and expandable reconstructions. Bone Joint J 96-B(11):1436\u20131440. https:\/\/doi.org\/10.1302\/0301-620X.96B11.34747","journal-title":"Bone Joint J"},{"issue":"6","key":"182_CR77","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00264-006-0192-x","volume":"30","author":"D Carrle","year":"2006","unstructured":"Carrle D, Bielack SS (2006) Current strategies of chemotherapy in osteosarcoma. Int Orthop 30(6):445\u2013451. https:\/\/doi.org\/10.1007\/s00264-006-0192-x","journal-title":"Int Orthop"},{"issue":"4","key":"182_CR78","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.mpsur.2021.01.009","volume":"39","author":"E Dickens","year":"2021","unstructured":"Dickens E, Ahmed S (2021) Principles of cancer treatment by chemotherapy. Surg Infect (Larchmt) 39(4):215\u2013220. https:\/\/doi.org\/10.1016\/j.mpsur.2021.01.009","journal-title":"Surg Infect (Larchmt)"},{"issue":"16","key":"182_CR79","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.ejca.2011.05.030","volume":"47","author":"JK Anninga","year":"2011","unstructured":"Anninga JK, Gelderblom H, Fiocco M et al (2011) Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer 47(16):2431\u20132445. https:\/\/doi.org\/10.1016\/j.ejca.2011.05.030","journal-title":"Eur J Cancer"},{"issue":"5","key":"182_CR80","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.suc.2016.06.002","volume":"96","author":"CJ Gutowski","year":"2016","unstructured":"Gutowski CJ, Basu-Mallick A, Abraham JA (2016) Management of bone sarcoma. Surg Clin N Am 96(5):1077\u20131106. https:\/\/doi.org\/10.1016\/j.suc.2016.06.002","journal-title":"Surg Clin N Am"},{"issue":"5","key":"182_CR81","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/(sici)1097-0215(20000301)85:5<659::Aid-ijc11>3.0.Co;2-5","volume":"85","author":"G Ragupathi","year":"2000","unstructured":"Ragupathi G, Meyers M, Adluri S et al (2000) Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-klh conjugate plus immunological adjuvant QS-21. Int J Cancer 85(5):659\u2013666. https:\/\/doi.org\/10.1002\/(sici)1097-0215(20000301)85:5%3c659::Aid-ijc11%3e3.0.Co;2-5","journal-title":"Int J Cancer"},{"issue":"8","key":"182_CR82","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3748\/wjg.v9.i8.1795","volume":"9","author":"YC He","year":"2003","unstructured":"He YC, Chen JW, Cao J et al (2003) Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats. World J Gastroenterol 9(8):1795\u20131798. https:\/\/doi.org\/10.3748\/wjg.v9.i8.1795","journal-title":"World J Gastroenterol"},{"issue":"4","key":"182_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1172\/JCI15223","volume":"110","author":"F Curnis","year":"2002","unstructured":"Curnis F, Sacchi A, Corti A (2002) Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. J Clin Invest 110(4):475\u2013482. https:\/\/doi.org\/10.1172\/JCI15223","journal-title":"J Clin Invest"},{"issue":"10","key":"182_CR84","first-page":"2363","volume":"59","author":"HP Schlemmer","year":"1999","unstructured":"Schlemmer HP, Becker M, Bachert P et al (1999) Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy. Cancer Res 59(10):2363\u20132369","journal-title":"Cancer Res"},{"issue":"2","key":"182_CR85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1211\/0022357021778268","volume":"54","author":"EP Goldberg","year":"2002","unstructured":"Goldberg EP, Hadba AR, Almond BA et al (2002) Intratumoral cancer chemotherapy and immunotherapy: Opportunities for nonsystemic preoperative drug delivery. J Pharm Pharmacol 54(2):159\u2013180. https:\/\/doi.org\/10.1211\/0022357021778268","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"182_CR86","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/jnci\/djj070","volume":"98","author":"MR Dreher","year":"2006","unstructured":"Dreher MR, Liu W, Michelich CR et al (2006) Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 98(5):335\u2013344. https:\/\/doi.org\/10.1093\/jnci\/djj070","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"182_CR87","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijrobp.2016.02.012","volume":"95","author":"R Imai","year":"2016","unstructured":"Imai R, Kamada T, Araki N et al (2016) Carbon ion radiation therapy for unresectable sacral chordoma: an analysis of 188 cases. Int J Radiat Oncol Biol Phys 95(1):322\u2013327. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.02.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"182_CR88","doi-asserted-by":"publisher","first-page":"E641","DOI":"10.1016\/j.ijrobp.2015.07.2184","volume":"93","author":"BC Baumann","year":"2015","unstructured":"Baumann BC, Lustig RA, Mazzoni S et al (2015) A prospective clinical trial of proton therapy for chordoma and chondrosarcoma. Int J Radiat Oncol 93(3):E641. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.07.2184","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"182_CR89","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ijrobp.2015.04.048","volume":"92","author":"CV Sole","year":"2015","unstructured":"Sole CV, Calvo FA, Polo A et al (2015) Intraoperative electron-beam radiation therapy for pediatric Ewing sarcomas and rhabdomyosarcomas: long-term outcomes. Int J Radiat Oncol Biol Phys 92(5):1069\u20131076. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.048","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"182_CR90","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.mpsur.2021.02.002","volume":"39","author":"JS Vaidya","year":"2021","unstructured":"Vaidya JS (2021) Principles of cancer treatment by radiotherapy. Surg Infect (Larchmt) 39(4):193\u2013201. https:\/\/doi.org\/10.1016\/j.mpsur.2021.02.002","journal-title":"Surg Infect (Larchmt)"},{"issue":"1","key":"182_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2045-3329-2-18","volume":"2","author":"A Berrington De Gonzalez","year":"2012","unstructured":"Berrington De Gonzalez A, Kutsenko A, Rajaraman P (2012) Sarcoma risk after radiation exposure. Clin Sarcoma Res 2(1):18. https:\/\/doi.org\/10.1186\/2045-3329-2-18","journal-title":"Clin Sarcoma Res"},{"issue":"12","key":"182_CR92","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1200\/Jco.2009.25.1728","volume":"28","author":"RA Gladdy","year":"2010","unstructured":"Gladdy RA, Qin LX, Moraco N et al (2010) Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol 28(12):2064\u20132069. https:\/\/doi.org\/10.1200\/Jco.2009.25.1728","journal-title":"J Clin Oncol"},{"issue":"5","key":"182_CR93","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2613.2010.00749.x","volume":"91","author":"N Jamil","year":"2010","unstructured":"Jamil N, Howie S, Salter DM (2010) Therapeutic molecular targets in human chondrosarcoma. Int J Exp Pathol 91(5):387\u2013393. https:\/\/doi.org\/10.1111\/j.1365-2613.2010.00749.x","journal-title":"Int J Exp Pathol"},{"issue":"8","key":"182_CR94","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1470-2045(05)70282-5","volume":"6","author":"JV Bovee","year":"2005","unstructured":"Bovee JV, Cleton-Jansen AM, Taminiau AH et al (2005) Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 6(8):599\u2013607. https:\/\/doi.org\/10.1016\/S1470-2045(05)70282-5","journal-title":"Lancet Oncol"},{"issue":"10043","key":"182_CR95","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","volume":"388","author":"GC Jayson","year":"2016","unstructured":"Jayson GC, Kerbel R, Ellis LM et al (2016) Antiangiogenic therapy in oncology: current status and future directions. Lancet 388(10043):518\u2013529. https:\/\/doi.org\/10.1016\/S0140-6736(15)01088-0","journal-title":"Lancet"},{"key":"182_CR96","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2017.03.037","volume":"79","author":"L Lebellec","year":"2017","unstructured":"Lebellec L, Chauffert B, Blay JY et al (2017) Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the french sarcoma group (GSF\/GETO) and the association des neuro-oncologues d\u2019expression francaise (ANOCEF). Eur J Cancer 79:119\u2013128. https:\/\/doi.org\/10.1016\/j.ejca.2017.03.037","journal-title":"Eur J Cancer"},{"issue":"3","key":"182_CR97","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/SPC.0b013e32835689cd","volume":"6","author":"RE Coleman","year":"2012","unstructured":"Coleman RE (2012) Adjuvant bone-targeted therapy to prevent metastasis: lessons from the azure study. Curr Opin Support Palliat Care 6(3):322\u2013329. https:\/\/doi.org\/10.1097\/SPC.0b013e32835689cd","journal-title":"Curr Opin Support Palliat Care"},{"issue":"11","key":"182_CR98","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrclinonc.2010.134","volume":"7","author":"T Onishi","year":"2010","unstructured":"Onishi T, Hayashi N, Theriault RL et al (2010) Future directions of bone-targeted therapy for metastatic breast cancer. Nat Rev Clin Oncol 7(11):641\u2013651. https:\/\/doi.org\/10.1038\/nrclinonc.2010.134","journal-title":"Nat Rev Clin Oncol"},{"key":"182_CR99","doi-asserted-by":"publisher","unstructured":"Rajan S, Cam M, Gross AC, et al (2020) Osteosarcoma tumors maintain intratumoral heterogeneity, even while adapting to environmental pressures that drive clonal selection. https:\/\/doi.org\/10.1101\/2020.11.03.367342","DOI":"10.1101\/2020.11.03.367342"},{"issue":"PtB","key":"182_CR100","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2015.11.017","volume":"99","author":"M Futakuchi","year":"2016","unstructured":"Futakuchi M, Fukamachi K, Suzui M (2016) Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer. Adv Drug Deliv Rev 99(PtB):206\u2013211. https:\/\/doi.org\/10.1016\/j.addr.2015.11.017","journal-title":"Adv Drug Deliv Rev"},{"key":"182_CR101","unstructured":"Targeted cancer drugs for bone cancer (2021) Cancer Research UK. https:\/\/www.cancerresearchuk.org\/about-cancer\/bone-cancer\/treatment\/Targeted-cancer-drugs. Accessed 1 July 2021"},{"issue":"7","key":"182_CR102","first-page":"452","volume":"42","author":"CL Ventola","year":"2017","unstructured":"Ventola CL (2017) Cancer immunotherapy, part 2: efficacy, safety, and other clinical considerations. Pharm Thr 42(7):452\u2013463","journal-title":"Pharm Thr"},{"issue":"1","key":"182_CR103","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1634\/theoncologist.2016-0025","volume":"23","author":"MJ Nathenson","year":"2018","unstructured":"Nathenson MJ, Conley AP, Sausville E (2018) Immunotherapy: a new (and old) approach to treatment of soft tissue and bone sarcomas. Oncologist 23(1):71\u201383. https:\/\/doi.org\/10.1634\/theoncologist.2016-0025","journal-title":"Oncologist"},{"key":"182_CR104","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/820813","volume":"2015","author":"T Uehara","year":"2015","unstructured":"Uehara T, Fujiwara T, Takeda K et al (2015) Immunotherapy for bone and soft tissue sarcomas. Biomed Res Int 2015:820813. https:\/\/doi.org\/10.1155\/2015\/820813","journal-title":"Biomed Res Int"},{"key":"182_CR105","first-page":"434","volume":"22","author":"RC Marcove","year":"1971","unstructured":"Marcove RC, Southam CM, Levin A et al (1971) A clinical trial of autogenous vaccine in osteogenic sarcoma in patients under the age of twenty-five. Surg Forum 22:434\u2013435","journal-title":"Surg Forum"},{"issue":"9","key":"182_CR106","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm1100","volume":"10","author":"SA Rosenberg","year":"2004","unstructured":"Rosenberg SA, Yang JC, Restifo NP (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10(9):909\u2013915. https:\/\/doi.org\/10.1038\/nm1100","journal-title":"Nat Med"},{"issue":"4","key":"182_CR107","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/01.cco.0000228743.72165.86","volume":"18","author":"RG Maki","year":"2006","unstructured":"Maki RG (2006) Future directions for immunotherapeutic intervention against sarcomas. Curr Opin Oncol 18(4):363\u2013368. https:\/\/doi.org\/10.1097\/01.cco.0000228743.72165.86","journal-title":"Curr Opin Oncol"},{"key":"182_CR108","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/596432","volume":"2010","author":"M Vergati","year":"2010","unstructured":"Vergati M, Intrivici C, Huen NY et al (2010) Strategies for cancer vaccine development. J Biomed Biotechnol 2010:596432. https:\/\/doi.org\/10.1155\/2010\/596432","journal-title":"J Biomed Biotechnol"},{"issue":"9","key":"182_CR109","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nrc1167","volume":"3","author":"ME Dudley","year":"2003","unstructured":"Dudley ME, Rosenberg SA (2003) Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer 3(9):666\u2013675. https:\/\/doi.org\/10.1038\/nrc1167","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"182_CR110","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/ni.2392","volume":"13","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) Immunology beats cancer: a blueprint for successful translation. Nat Immunol 13(12):1129\u20131132. https:\/\/doi.org\/10.1038\/ni.2392","journal-title":"Nat Immunol"},{"issue":"4","key":"182_CR111","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.3390\/cancers3043856","volume":"3","author":"S Lee","year":"2011","unstructured":"Lee S, Margolin K (2011) Cytokines in cancer immunotherapy. Cancers (Basel) 3(4):3856\u20133893. https:\/\/doi.org\/10.3390\/cancers3043856","journal-title":"Cancers (Basel)"},{"issue":"10","key":"182_CR112","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/1097-0142(19941115)74:10<2798::Aid-cncr2820741009>3.0.Co;2-2","volume":"74","author":"Y Ogihara","year":"1994","unstructured":"Ogihara Y, Takeda K, Yanagawa T et al (1994) Spontaneous regression of lung metastases from osteosarcoma. Cancer 74(10):2798\u20132803. https:\/\/doi.org\/10.1002\/1097-0142(19941115)74:10%3c2798::Aid-cncr2820741009%3e3.0.Co;2-2","journal-title":"Cancer"},{"issue":"3","key":"182_CR113","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2214\/ajr.171.3.9725297","volume":"171","author":"JM Sabate","year":"1998","unstructured":"Sabate JM, Llauger J, Torrubia S et al (1998) Osteosarcoma of the abdominal wall with spontaneous regression of lung metastases. AJR Am J Roentgenol 171(3):691\u2013692. https:\/\/doi.org\/10.2214\/ajr.171.3.9725297","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"182_CR114","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00776-003-0663-5","volume":"8","author":"Y Nabeta","year":"2003","unstructured":"Nabeta Y, Kawaguchi S, Sahara H et al (2003) Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line. J Orthop Sci 8(4):554\u2013559. https:\/\/doi.org\/10.1007\/s00776-003-0663-5","journal-title":"J Orthop Sci"},{"issue":"9","key":"182_CR115","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.4049\/jimmunol.137.9.3042","volume":"137","author":"SF Slovin","year":"1986","unstructured":"Slovin SF, Lackman RD, Ferrone S et al (1986) Cellular immune response to human sarcomas: cytotoxic t cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity. J Immunol 137(9):3042\u20133048","journal-title":"J Immunol"},{"issue":"3","key":"182_CR116","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.4049\/jimmunol.169.3.1611","volume":"169","author":"Y Sato","year":"2002","unstructured":"Sato Y, Nabeta Y, Tsukahara T et al (2002) Detection and induction of CTLs specific for syt-ssx-derived peptides in HLA-A24+ patients with synovial sarcoma. J Immunol 169(3):1611\u20131618. https:\/\/doi.org\/10.4049\/jimmunol.169.3.1611","journal-title":"J Immunol"},{"issue":"18","key":"182_CR117","first-page":"6868","volume":"61","author":"BS Worley","year":"2001","unstructured":"Worley BS, Van Den Broeke LT, Goletz TJ et al (2001) Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations. Cancer Res 61(18):6868\u20136875","journal-title":"Cancer Res"},{"issue":"9","key":"182_CR118","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/bph.14999","volume":"178","author":"MF Heymann","year":"2021","unstructured":"Heymann MF, Schiavone K, Heymann D (2021) Bone sarcomas in the immunotherapy era. Br J Pharmacol 178(9):1955\u20131972. https:\/\/doi.org\/10.1111\/bph.14999","journal-title":"Br J Pharmacol"},{"issue":"2","key":"182_CR119","doi-asserted-by":"publisher","first-page":"266","DOI":"10.18063\/ijb.v6i2.266","volume":"6","author":"Y Hou","year":"2020","unstructured":"Hou Y, Wang W, Bartolo PJDS (2020) Investigating the effect of carbon nanomaterials reinforcing ooly (\u03b5-caprolactone) printed scaffolds for bone repair applications. Int J Bioprint 6(2):266. https:\/\/doi.org\/10.18063\/ijb.v6i2.266","journal-title":"Int J Bioprint"},{"issue":"5","key":"182_CR120","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1089\/3dp.2020.0051","volume":"7","author":"YH Hou","year":"2020","unstructured":"Hou YH, Wang WG, Bartolo P (2020) Novel poly(e-caprolactone)\/graphene scaffolds for bone cancer treatment and bone regeneration. 3D Print Addit Manuf 7(5):222\u2013229. https:\/\/doi.org\/10.1089\/3dp.2020.0051","journal-title":"3D Print Addit Manuf"},{"key":"182_CR121","doi-asserted-by":"publisher","first-page":"108763","DOI":"10.1016\/j.compscitech.2021.108763","volume":"208","author":"SS Zhu","year":"2021","unstructured":"Zhu SS, Yao LY, Pan CL et al (2021) 3D printed gellan gum\/graphene oxide scaffold for tumor therapy and bone reconstruction. Comp Sci Technol 208:108763. https:\/\/doi.org\/10.1016\/j.compscitech.2021.108763","journal-title":"Comp Sci Technol"},{"key":"182_CR122","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jcis.2020.06.122","volume":"579","author":"M Hu","year":"2020","unstructured":"Hu M, Fang J, Zhang Y et al (2020) Design and evaluation a kind of functional biomaterial for bone tissue engineering: Selenium\/mesoporous bioactive glass nanospheres. J Colloid Interface Sci 579:654\u2013666. https:\/\/doi.org\/10.1016\/j.jcis.2020.06.122","journal-title":"J Colloid Interface Sci"},{"issue":"2","key":"182_CR123","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/j.ceramint.2015.11.024","volume":"42","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang Y, Ma Y et al (2016) Selenium - containing mesoporous bioactive glass particles: Physicochemical and drug delivery properties. Ceram Int 42(2):3609\u20133617. https:\/\/doi.org\/10.1016\/j.ceramint.2015.11.024","journal-title":"Ceram Int"},{"key":"182_CR124","doi-asserted-by":"publisher","first-page":"123329","DOI":"10.1016\/j.matchemphys.2020.123329","volume":"253","author":"N Sarin","year":"2020","unstructured":"Sarin N, Singh KJ, Singh D et al (2020) Preliminary studies of strontium and selenium binary doped CaO-SiO2-P2O5-MgO bioceramics for faster growth of hydroxyapatite and bone regeneration applications. Mater Chem Phys 253:123329. https:\/\/doi.org\/10.1016\/j.matchemphys.2020.123329","journal-title":"Mater Chem Phys"},{"issue":"11","key":"182_CR125","doi-asserted-by":"publisher","first-page":"9927","DOI":"10.1021\/acsnano.6b03835","volume":"10","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang J, Hao H et al (2016) In vitro and in vivo mechanism of bone tumor inhibition by selenium-doped bone mineral nanoparticles. ACS Nano 10(11):9927\u20139937. https:\/\/doi.org\/10.1021\/acsnano.6b03835","journal-title":"ACS Nano"},{"key":"182_CR126","doi-asserted-by":"publisher","first-page":"120253","DOI":"10.1016\/j.biomaterials.2020.120253","volume":"257","author":"X Li","year":"2020","unstructured":"Li X, Wang Y, Chen Y et al (2020) Hierarchically constructed selenium-doped bone-mimetic nanoparticles promote ROS-mediated autophagy and apoptosis for bone tumor inhibition. Biomaterials 257:120253. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120253","journal-title":"Biomaterials"},{"key":"182_CR127","doi-asserted-by":"publisher","first-page":"118638","DOI":"10.1016\/j.ijpharm.2019.118638","volume":"570","author":"P Zhao","year":"2019","unstructured":"Zhao P, Li M, Chen Y et al (2019) Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects. Int J Pharm 570:118638. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118638","journal-title":"Int J Pharm"},{"issue":"11","key":"182_CR128","doi-asserted-by":"publisher","first-page":"13787","DOI":"10.1016\/j.ceramint.2019.04.075","volume":"45","author":"L He","year":"2019","unstructured":"He L, Li HY, Chen XY et al (2019) Selenium-substituted hydroxyapatite particles with regulated microstructures for osteogenic differentiation and anti-tumor effects. Ceram Int 45(11):13787\u201313798. https:\/\/doi.org\/10.1016\/j.ceramint.2019.04.075","journal-title":"Ceram Int"},{"issue":"14","key":"182_CR129","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1039\/d0tb00390e","volume":"8","author":"A Barbanente","year":"2020","unstructured":"Barbanente A, Nadar RA, Degli Esposti L et al (2020) Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells. J Mater Chem B 8(14):2792\u20132804. https:\/\/doi.org\/10.1039\/d0tb00390e","journal-title":"J Mater Chem B"},{"key":"182_CR130","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fonc.2019.00499","volume":"9","author":"S Khan","year":"2019","unstructured":"Khan S, Ullah MW, Siddique R et al (2019) Catechins-modified selenium-doped hydroxyapatite nanomaterials for improved osteosarcoma therapy through generation of reactive oxygen species. Front Oncol 9:499. https:\/\/doi.org\/10.3389\/fonc.2019.00499","journal-title":"Front Oncol"},{"key":"182_CR131","doi-asserted-by":"publisher","first-page":"111334","DOI":"10.1016\/j.jinorgbio.2020.111334","volume":"215","author":"A Barbanente","year":"2021","unstructured":"Barbanente A, Palazzo B, Esposti LD et al (2021) Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy. J Inorg Biochem 215:111334. https:\/\/doi.org\/10.1016\/j.jinorgbio.2020.111334","journal-title":"J Inorg Biochem"},{"key":"182_CR132","doi-asserted-by":"publisher","first-page":"126408","DOI":"10.1016\/j.surfcoat.2020.126408","volume":"403","author":"JH Zhou","year":"2020","unstructured":"Zhou JH, Wang XL (2020) The osteogenic, anti-oncogenic and antibacterial activities of selenium-doped titanium dioxide coatings on titanium. Surf Coat Tech 403:126408. https:\/\/doi.org\/10.1016\/j.surfcoat.2020.126408","journal-title":"Surf Coat Tech"},{"key":"182_CR133","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.colsurfb.2012.10.022","volume":"103","author":"XY Chen","year":"2013","unstructured":"Chen XY, Cai KY, Fang JJ et al (2013) Fabrication of selenium-deposited and chitosan-coated titania nanotubes with anticancer and antibacterial properties. Colloid Surface B 103:149\u2013157. https:\/\/doi.org\/10.1016\/j.colsurfb.2012.10.022","journal-title":"Colloid Surface B"},{"issue":"4","key":"182_CR134","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/jbm.a.32631","volume":"93a","author":"PA Tran","year":"2010","unstructured":"Tran PA, Sarin L, Hurt RH et al (2010) Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material. J Biomed Mater Res Part A 93a(4):1417\u20131428. https:\/\/doi.org\/10.1002\/jbm.a.32631","journal-title":"J Biomed Mater Res Part A"},{"issue":"2","key":"182_CR135","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jbm.a.35583","volume":"104","author":"M Stolzoff","year":"2016","unstructured":"Stolzoff M, Webster TJ (2016) Reducing bone cancer cell functions using selenium nanocomposites. J Biomed Mater Res Part A 104(2):476\u2013482. https:\/\/doi.org\/10.1002\/jbm.a.35583","journal-title":"J Biomed Mater Res Part A"},{"issue":"3","key":"182_CR136","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/0885328220933781","volume":"35","author":"Z Karahaliloglu","year":"2020","unstructured":"Karahaliloglu Z, Kilicay E (2020) In vitro evaluation of bone cements impregnated with selenium nanoparticles stabilized by phosphatidylcholine (PC) for application in bone. J Biomater Appl 35(3):385\u2013404. https:\/\/doi.org\/10.1177\/0885328220933781","journal-title":"J Biomater Appl"},{"key":"182_CR137","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.msec.2018.11.073","volume":"96","author":"N Filipovic","year":"2019","unstructured":"Filipovic N, Veselinovic L, Razic S et al (2019) Poly (epsilon-caprolactone) microspheres for prolonged release of selenium nanoparticles. Mat Sci Eng C Mater 96:776\u2013789. https:\/\/doi.org\/10.1016\/j.msec.2018.11.073","journal-title":"Mat Sci Eng C Mater"},{"key":"182_CR138","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.2147\/IJN.S33083","volume":"7","author":"M Chen","year":"2012","unstructured":"Chen M, Le DQ, Hein S et al (2012) Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release. Int J Nanomed 7:4285\u20134297. https:\/\/doi.org\/10.2147\/IJN.S33083","journal-title":"Int J Nanomed"},{"key":"182_CR139","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.actbio.2020.10.006","volume":"118","author":"CA Lahr","year":"2020","unstructured":"Lahr CA, Landgraf M, Sanchez-Herrero A et al (2020) A 3D-printed biomaterials-based platform to advance established therapy avenues against primary bone cancers. Acta Biomater 118:69\u201382. https:\/\/doi.org\/10.1016\/j.actbio.2020.10.006","journal-title":"Acta Biomater"},{"issue":"6","key":"182_CR140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.25125\/engineering-journal-IJOER-JUN-2017-12","volume":"3","author":"GV Salmoria","year":"2017","unstructured":"Salmoria GV, Vieira FE, Ghizoni GB et al (2017) Additive manufacturing of PE\/fluorouracil waffles for implantable drug delivery in bone cancer treatment. Inter J Eng Res Sci 3(6):62\u201370","journal-title":"Inter J Eng Res Sci"},{"key":"182_CR141","first-page":"6","volume":"4","author":"GV Salmoria","year":"2017","unstructured":"Salmoria GV, Vieira F, Ghizoni G et al (2017) 3D printing of PCL\/fluorouracil tablets by selective laser sintering: properties of implantable drug delivery for cartilage cancer treatment. Drugs 4:6","journal-title":"Drugs"},{"key":"182_CR142","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.polymertesting.2018.09.023","volume":"71","author":"GV Salmoria","year":"2018","unstructured":"Salmoria GV, Vieira FE, Muenz EA et al (2018) Additive manufacturing of PE\/fluorouracil\/progesterone intrauterine device for endometrial and ovarian cancer treatments. Polym Test 71:312\u2013317. https:\/\/doi.org\/10.1016\/j.polymertesting.2018.09.023","journal-title":"Polym Test"},{"key":"182_CR143","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/j.matdes.2019.108336","volume":"186","author":"YH Wang","year":"2020","unstructured":"Wang YH, Sun L, Mei ZG et al (2020) 3D printed biodegradable implants as an individualized drug delivery system for local chemotherapy of osteosarcoma. Mater Des 186:108336. https:\/\/doi.org\/10.1016\/j.matdes.2019.108336","journal-title":"Mater Des"},{"key":"182_CR144","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2016.06.015","volume":"238","author":"HG Yi","year":"2016","unstructured":"Yi HG, Choi YJ, Kang KS et al (2016) A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Controll Rel 238:231\u2013241. https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.015","journal-title":"J Controll Rel"},{"key":"182_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119618","volume":"230","author":"Y Yang","year":"2020","unstructured":"Yang Y, Qiao X, Huang R et al (2020) E-jet 3D printed drug delivery implants to inhibit growth and metastasis of orthotopic breast cancer. Biomaterials 230:119618. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119618","journal-title":"Biomaterials"},{"issue":"2","key":"182_CR146","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/acs.molpharmaceut.8b00836","volume":"16","author":"H Cho","year":"2019","unstructured":"Cho H, Jammalamadaka U, Tappa K et al (2019) 3D printing of poloxamer 407 nanogel discs and their applications in adjuvant ovarian cancer therapy. Mol Pharm 16(2):552\u2013560. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00836","journal-title":"Mol Pharm"},{"issue":"9","key":"182_CR147","doi-asserted-by":"publisher","first-page":"2000056","DOI":"10.1002\/adtp.202000056","volume":"3","author":"D Hoang Phuc","year":"2020","unstructured":"Hoang Phuc D, Shafiee A, Lahr CA et al (2020) Local doxorubicin delivery via 3D-printed porous scaffolds reduces systemic cytotoxicity and breast cancer recurrence in mice. Adv Ther 3(9):2000056. https:\/\/doi.org\/10.1002\/adtp.202000056","journal-title":"Adv Ther"},{"issue":"35","key":"182_CR148","doi-asserted-by":"publisher","first-page":"29562","DOI":"10.1021\/acsami.7b09916","volume":"9","author":"S Maher","year":"2017","unstructured":"Maher S, Kaur G, Lima-Marques L et al (2017) Engineering of micro- to nanostructured 3D-printed drug-releasing titanium implants for enhanced osseointegration and localized delivery of anticancer drugs. ACS Appl Mater Interf 9(35):29562\u201329570. https:\/\/doi.org\/10.1021\/acsami.7b09916","journal-title":"ACS Appl Mater Interf"},{"issue":"43","key":"182_CR149","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.1039\/c4tb01063a","volume":"2","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhao S, Zhu M et al (2014) 3D-printed magnetic Fe3O4\/MBG\/PCL composite scaffolds with multifunctionality of bone regeneration, local anticancer drug delivery and hyperthermia. J Mater Chem B 2(43):7583\u20137595. https:\/\/doi.org\/10.1039\/c4tb01063a","journal-title":"J Mater Chem B"},{"issue":"4","key":"182_CR150","doi-asserted-by":"publisher","first-page":"1907071","DOI":"10.1002\/adfm.201907071","volume":"30","author":"S Dong","year":"2020","unstructured":"Dong S, Chen Y, Yu L et al (2020) Magnetic hyperthermia-synergistic H2O2 self-sufficient catalytic suppression of osteosarcoma with enhanced bone-regeneration bioactivity by 3D-printing composite scaffolds. Adv Funct Mater 30(4):1907071. https:\/\/doi.org\/10.1002\/adfm.201907071","journal-title":"Adv Funct Mater"},{"key":"182_CR151","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1038\/am.2017.47","volume":"9","author":"XC Wang","year":"2017","unstructured":"Wang XC, Li T, Ma HS et al (2017) A 3D-printed scaffold with MoS2 nanosheets for tumor therapy and tissue regeneration. NPG Asia Mater 9:e376. https:\/\/doi.org\/10.1038\/am.2017.47","journal-title":"NPG Asia Mater"},{"issue":"12","key":"182_CR152","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.1021\/acsbiomaterials.9b01095","volume":"5","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Lin R, Liu Y et al (2019) Three-dimensional-printed bioceramic scaffolds with osteogenic activity for simultaneous photo\/magnetothermal therapy of bone tumors. ACS Biomater Sci Eng 5(12):6725\u20136734. https:\/\/doi.org\/10.1021\/acsbiomaterials.9b01095","journal-title":"ACS Biomater Sci Eng"},{"issue":"14","key":"182_CR153","doi-asserted-by":"publisher","first-page":"1906814","DOI":"10.1002\/smll.201906814","volume":"16","author":"Q Yang","year":"2020","unstructured":"Yang Q, Yin H, Xu T et al (2020) Engineering 2D mesoporous silica@MXene-integrated 3D-printing scaffolds for combinatory osteosarcoma therapy and NO-augmented bone regeneration. Small 16(14):1906814. https:\/\/doi.org\/10.1002\/smll.201906814","journal-title":"Small"},{"issue":"2","key":"182_CR154","doi-asserted-by":"publisher","first-page":"1901511","DOI":"10.1002\/advs.201901511","volume":"7","author":"S Pan","year":"2020","unstructured":"Pan S, Yin J, Yu L et al (2020) 2D mxene-integrated 3D-printing scaffolds for augmented osteosarcoma phototherapy and accelerated tissue reconstruction. Adv Sci 7(2):1901511. https:\/\/doi.org\/10.1002\/advs.201901511","journal-title":"Adv Sci"},{"key":"182_CR155","doi-asserted-by":"publisher","first-page":"125081","DOI":"10.1016\/j.cej.2020.125081","volume":"396","author":"H Wang","year":"2020","unstructured":"Wang H, Zeng XQ, Pang LB et al (2020) Integrative treatment of anti-tumor\/bone repair by combination of MoS2 nanosheets with 3D printed bioactive borosilicate glass scaffolds. Chem Eng J 396:125081. https:\/\/doi.org\/10.1016\/j.cej.2020.125081","journal-title":"Chem Eng J"},{"key":"182_CR156","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biomaterials.2017.11.020","volume":"160","author":"W Dang","year":"2018","unstructured":"Dang W, Li T, Li B et al (2018) A bifunctional scaffold with CuFeSe2 nanocrystals for tumor therapy and bone reconstruction. Biomaterials 160:92\u2013106. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.11.020","journal-title":"Biomaterials"},{"key":"182_CR157","doi-asserted-by":"publisher","first-page":"129919","DOI":"10.1016\/j.cej.2021.129919","volume":"422","author":"WT Dang","year":"2021","unstructured":"Dang WT, Jin YY, Yi K et al (2021) Hemin particles-functionalized 3D printed scaffolds for combined photothermal and chemotherapy of osteosarcoma. Chem Eng J 422:129919. https:\/\/doi.org\/10.1016\/j.cej.2021.129919","journal-title":"Chem Eng J"},{"key":"182_CR158","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.actbio.2018.04.014","volume":"73","author":"YQ Liu","year":"2018","unstructured":"Liu YQ, Li T, Ma HS et al (2018) 3D-printed scaffolds with bioactive elements-induced photothermal effect for bone tumor therapy. Acta Biomater 73:531\u2013546. https:\/\/doi.org\/10.1016\/j.actbio.2018.04.014","journal-title":"Acta Biomater"},{"key":"182_CR159","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41427-018-0015-8","volume":"10","author":"HS Ma","year":"2018","unstructured":"Ma HS, Li T, Huan ZG et al (2018) 3D printing of high-strength bioscaffolds for the synergistic treatment of bone cancer. NPG Asia Mater 10:31\u201344. https:\/\/doi.org\/10.1038\/s41427-018-0015-8","journal-title":"NPG Asia Mater"},{"key":"182_CR160","doi-asserted-by":"publisher","first-page":"122928","DOI":"10.1016\/j.cej.2019.122928","volume":"382","author":"SY Fu","year":"2020","unstructured":"Fu SY, Hu HR, Chen JJ et al (2020) Silicone resin derived larnite\/C scaffolds via 3D printing for potential tumor therapy and bone regeneration. Chem Eng J 382:122928. https:\/\/doi.org\/10.1016\/j.cej.2019.122928","journal-title":"Chem Eng J"},{"key":"182_CR161","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.biomaterials.2016.10.005","volume":"111","author":"HS Ma","year":"2016","unstructured":"Ma HS, Luo J, Sun Z et al (2016) 3D printing of biomaterials with mussel-inspired nanostructures for tumor therapy and tissue regeneration. Biomaterials 111:138\u2013148. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.10.005","journal-title":"Biomaterials"},{"issue":"8","key":"182_CR162","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/adfm.201504142","volume":"26","author":"H Ma","year":"2016","unstructured":"Ma H, Jiang C, Zhai D et al (2016) A bifunctional biomaterial with photothermal effect fortumor therapy and bone regeneration. Adv Funct Mater 26(8):1197\u20131208. https:\/\/doi.org\/10.1002\/adfm.201504142","journal-title":"Adv Funct Mater"},{"issue":"3","key":"182_CR163","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1039\/c9tb02383f","volume":"8","author":"S Dong","year":"2020","unstructured":"Dong S, Zhang YN, Wan J et al (2020) A novel multifunctional carbon aerogel-coated platform for osteosarcoma therapy and enhanced bone regeneration. J Mater Chem B 8(3):368\u2013379. https:\/\/doi.org\/10.1039\/c9tb02383f","journal-title":"J Mater Chem B"},{"key":"182_CR164","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.apmt.2019.04.015","volume":"16","author":"WT Dang","year":"2019","unstructured":"Dang WT, Ma B, Huan ZG et al (2019) LaB6 surface chemistry-reinforced scaffolds for treating bone tumors and bone defects. Appl Mater Today 16:42\u201355. https:\/\/doi.org\/10.1016\/j.apmt.2019.04.015","journal-title":"Appl Mater Today"},{"issue":"1\u20134","key":"182_CR165","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00170-019-03866-0","volume":"104","author":"AA Al-Tamimi","year":"2019","unstructured":"Al-Tamimi AA, Huang BY, Vyas C et al (2019) Topology optimised metallic bone plates produced by electron beam melting: a mechanical and biological study. Int J Adv Manuf Tech 104(1\u20134):195\u2013210. https:\/\/doi.org\/10.1007\/s00170-019-03866-0","journal-title":"Int J Adv Manuf Tech"},{"issue":"3\u20134","key":"182_CR166","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00170-020-05676-1","volume":"109","author":"AA Al-Tamimi","year":"2020","unstructured":"Al-Tamimi AA, Hernandez MA, Omar A et al (2020) Mechanical, biological and tribological behaviour of fixation plates 3D printed by electron beam and selective laser melting. Int J Adv Manuf Tech 109(3\u20134):673\u2013688. https:\/\/doi.org\/10.1007\/s00170-020-05676-1","journal-title":"Int J Adv Manuf Tech"},{"key":"182_CR167","doi-asserted-by":"publisher","unstructured":"Kanczler JM, Wells JA, Gibbs DMR et al (2020) Chapter 50-bone tissue engineering and bone regeneration. In: Principles of tissue engineering, 5th edn. Academic Press, pp 917\u2013935. https:\/\/doi.org\/10.1016\/B978-0-12-818422-6.00052-6","DOI":"10.1016\/B978-0-12-818422-6.00052-6"},{"key":"182_CR168","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40204-014-0026-7","volume":"3","author":"B Thavornyutikarn","year":"2014","unstructured":"Thavornyutikarn B, Chantarapanich N, Sitthiseripratip K et al (2014) Bone tissue engineering scaffolding: computer-aided scaffolding techniques. Prog Biomater 3:61\u2013102. https:\/\/doi.org\/10.1007\/s40204-014-0026-7","journal-title":"Prog Biomater"},{"issue":"3","key":"182_CR169","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bioactmat.2017.10.001","volume":"3","author":"G Turnbull","year":"2018","unstructured":"Turnbull G, Clarke J, Picard F et al (2018) 3D bioactive composite scaffolds for bone tissue engineering. Bioact Mater 3(3):278\u2013314. https:\/\/doi.org\/10.1016\/j.bioactmat.2017.10.001","journal-title":"Bioact Mater"},{"key":"182_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2021.04.273","author":"S Kalsi","year":"2021","unstructured":"Kalsi S, Singh J, Sehgal SS et al (2021) Biomaterials for tissue engineered bone scaffolds: a review. Mate Today Proc. https:\/\/doi.org\/10.1016\/j.matpr.2021.04.273","journal-title":"Mate Today Proc"},{"issue":"8","key":"182_CR171","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41578-020-0204-2","volume":"5","author":"GL Koons","year":"2020","unstructured":"Koons GL, Diba M, Mikos AG (2020) Materials design for bone-tissue engineering. Nat Rev Mater 5(8):584\u2013603. https:\/\/doi.org\/10.1038\/s41578-020-0204-2","journal-title":"Nat Rev Mater"},{"issue":"4\u20135","key":"182_CR172","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.addr.2007.03.011","volume":"59","author":"WJEM Habraken","year":"2007","unstructured":"Habraken WJEM, Wolke JGC, Jansen JA (2007) Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Del Rev 59(4\u20135):234\u2013248. https:\/\/doi.org\/10.1016\/j.addr.2007.03.011","journal-title":"Adv Drug Del Rev"}],"container-title":["Bio-Design and Manufacturing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42242-022-00182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42242-022-00182-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42242-022-00182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T14:20:22Z","timestamp":1674915622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42242-022-00182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":172,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1007\/s42242-022-00182-7","relation":{},"ISSN":["2096-5524","2522-8552"],"issn-type":[{"value":"2096-5524","type":"print"},{"value":"2522-8552","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"3 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}